Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System
Condition(s):Type 1 DiabetesLast Updated:October 12, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Type 1 DiabetesLast Updated:October 12, 2022Completed
Condition(s):Type 1 DiabetesLast Updated:March 6, 2024Active, not recruiting
Condition(s):Behavioural Science Interventions to Improve Health EquityLast Updated:January 10, 2024Enrolling by invitation
Condition(s):Comorbidity; Multimorbidity; Drug Prescribing; Cognitive Impairment; Language ProblemsLast Updated:April 13, 2021Completed
Condition(s):Malnutrition; SurgeryLast Updated:July 20, 2023Recruiting
Condition(s):CannabisLast Updated:August 21, 2023Suspended
Condition(s):Adverse Outcomes Post-hospital DischargeLast Updated:September 16, 2013Completed
Condition(s):Cardiometabolic Syndrome; ObesityLast Updated:March 25, 2024Recruiting
Condition(s):Opioid Use; Opioid-use Disorder; SuicideLast Updated:August 31, 2023Completed
Condition(s):Urologic Diseases; Hypospadias; Undescended Testes; Chordee; Hydrocele; OrchiectomyLast Updated:December 26, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.